Global In-Vitro Diagnostics Market

October 2024 | 169 pages | ID: G653A2CA7A84EN
Evolve Business Intelligence

Abstracts

Global In-vitr-diagnostics (IVD) Market By Offerings (Reagents, Instruments, and Software And Services), By Technology (Immunodiagnostics, Hematology, Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, Microbiology, Coagulation & Hemostasis, and Others), By Application (Infectious Diseases, Oncology, Endocrinology, Cardiology, Blood Screening, Genetic Testing, Autoimmune Diseases, Allergy Diagnostics, Bone & Mineral Disorders, Coagulation Testing, and Others) , By End User (Hospital & Clinics, Clinical Laboratories, Point of Care, Pharmaceutical & Biotechnology Companies, Academic Institutes, and Others) And By Geography – Covid-19 Impact Analysis, Post Covid Analysis, Opportunities, Trends And Forecast From 2021 t-2034

The global In-Vitr-Diagnostics market was valued at $92.1 billion in 2023 and is anticipated t-grow at a CAGR of 7.2% from 2024 t-2034. This growth is attributed t-several macr-and microeconomic factors such as

• Rising numbers of Infectious Diseases and Chronic Disease

One of the foremost factors driving the growth of the In-Vitr-Diagnostics (IVD) market is the increasing incidence of infectious diseases globally. Infectious diseases, such as HIV, tuberculosis, malaria, and more recently, COVID-19, have underscored the critical need for reliable, rapid, and accurate diagnostic tools. The COVID-19 pandemic, in particular, highlighted the importance of molecular diagnostics like PCR tests, which became essential for detecting and controlling the spread of the virus. This heightened awareness and the subsequent investment in diagnostic infrastructure are expected t-have a lasting impact on the IVD market. Furthermore, the ongoing threat of emerging and re-emerging pathogens demands continuous advancements in diagnostic technologies t-ensure timely and effective responses t-future outbreaks. The demand for diagnostics in infectious disease management extends beyond just identifying the presence of pathogens. It includes monitoring disease progression, guiding treatment decisions, and conducting surveillance t-track the spread and evolution of diseases. Innovations in molecular diagnostics, such as next-generation sequencing (NGS), have enabled more comprehensive and precise pathogen detection, including the identification of new variants and antimicrobial resistance genes. These advancements are crucial for implementing effective public health measures and personalized treatment plans, further driving the growth of the IVD market.

Further several factors restraining the market growth include

• Rise in Aging Population

The aging population is a significant driver of growth in the In-Vitr-Diagnostics (IVD) market, majorly due t-the demand for diagnostic tests and technologies. People are more prone t-developing chronic diseases such as cardiovascular diseases, diabetes, cancer, and neurodegenerative disorders due t-aging. These conditions often require regular monitoring and early diagnosis t-manage effectively. IVD plays a vital role in detecting these diseases at an early stage, enabling timely interventions and improving patient outcomes. Consequently, the increasing number of elderly individuals globally has led t-a higher demand for various diagnostic tests, propelling the growth of the IVD market. As the global population ages, the incidence of conditions such as hypertension, diabetes, and osteoporosis rises. These conditions often necessitate routine blood tests, urine tests, and other diagnostic procedures t-monitor disease progression and manage treatment. For instance, diabetic patients require regular blood glucose monitoring, while those with cardiovascular conditions need lipid profile tests. The growing burden of these chronic diseases among the elderly population has significantly contributed t-the expansion of the IVD market, as healthcare providers rely on diagnostic tests t-deliver effective care.

Growth in untapped emerging markets and the rise of personalized medicine are expected t-generate higher avenues during the forecast period.

In the wake of the COVID-19 pandemic, supply chain disruptions have led t-supply shortages or lower demand in the In-vitr-diagnostics (IVD) market. The pandemic has caused a decline in new orders and a corresponding decrease in production.

This section will analyze how COVID-19 has impacted supply chains, leading t-shortages and lower demand for In-vitr-diagnostics (IVD).

In terms of COVID-19 impact, the In-vitr-diagnostics (IVD) market report als-includes the following data points:

• Impact on In-vitr-diagnostics (IVD) market size
• Operating Weights Trend, Preferences, and Budget Impact
• Regulatory Framework/Outdoor Policies
• Key Players' Strategy t-Tackle Negative Impact/Post-COVID Strategies
• Opportunity in the In-vitr-diagnostics (IVD) market

Key Insight in the report:

The global In-vitr-diagnostics (IVD) market report covers an executive summary, market dynamics, COVID impact & post-COVID scenario, market size and forecast, competitive intelligence, market positioning, and Product Types.

Our report covers extensive competitive intelligence which includes the following data points:

• Business Overview
• Business Segment Data
• Financial Data
• Product Type Segment Analysis and Specification
• Recent Development and Company Strategy Analysis
• SWOT Analysis

In-vitr-diagnostics (IVD) Market Segmentation:

• Offerings
• Reagents
• Instruments
• Software And Services
• Technology
• Immunodiagnostics
• Hematology
• Molecular Diagnostics
• Tissue Diagnostics
• Clinical Chemistry
• Microbiology
• Coagulation & Hemostasis
• Others
• Application
• Infectious Diseases
• Oncology
• Endocrinology
• Cardiology
• Blood Screening
• Genetic Testing
• Autoimmune Diseases
• Allergy Diagnostics
• Bone & Mineral Disorders
• Coagulation Testing
• Others
• End User
• Hospital & Clinics
• Clinical Laboratories
• Point of Care
• Pharmaceutical & Biotechnology Companies
• Academic Institutes
• Others

Region/ Countries Covered:

• North America
• US
• Canada
• Mexico
• Europe
• U.K.
• Germany
• France
• Italy
• Spain
• BeNeLux
• Nordic
• Rest of Europe
• Asia Pacific
• China
• Japan
• Australia
• India
• South Korea
• Thailand
• Indonesia
• Malaysia
• Rest of Asia Pacific
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest of Middle East & Africa

Key Players Analyzed in the Report:

• Abbott Laboratories
• Becton, Dickinson and Company
• bioMйrieux
• Bio-Rad Laboratories Inc
• Danaher Corporation (Beckman Coulter, Inc.)
• Hoffmann-La Roche
• Siemens
• QIAGEN N.V.
• Sysmex Corporation
• Therm-Fisher Scientific Inc

Contents

CHAPTER 1. EXECUTIVE SUMMARY

CHAPTER 2. SCOPE OF THE STUDY

2.1. Market Definition
2.2. Market Scope & Segmentation
  2.2.1. Objective of Report

CHAPTER 3. EVOLVE BI METHODOLOGY

3.1. Data Collection & Validation Approach
3.2. Market Size Estimation and Forecast

CHAPTER 4. MARKET INSIGHTS AND TRENDS

4.1. Value Chain Analysis
  4.1.1. Research & Development
  4.1.2. Manufacturing Process
  4.1.3. Distribution Channel
  4.1.4. End-User
4.2. Porter’s Five Forces Analysis
  4.2.1. Bargaining Power of Buyers
  4.2.2. Bargaining Power of Suppliers
  4.2.3. Threat of New Entrant
  4.2.4. Threat of Substitute
  4.2.5. Industry Rivalry
4.3. COVID-19 Impact and Post COVID Scenario on In-Vitro Diagnostics Market
  4.3.1. Impact of COVID-19
  4.3.2. Government Support and Industry Revival Policies
  4.3.3. Measures Taken by Companies to Mitigate Negative Impact
  4.3.4. Post COVID Trend

CHAPTER 5. MARKET DYNAMICS

5.1. Introduction
5.2. Drivers
  5.2.1. Rising numbers of Infectious Diseases and Chronic Disease
  5.2.2. Rise in Aging Population
  5.2.3. Increased Healthcare Spending
5.3. Restraints
  5.3.1. Unfavorable Reimbursement Scenarios
  5.3.2. Rising Healthcare Costs
5.4. Opportunity
  5.4.1. Growth in untapped emerging markets
  5.4.2. The rise of personalized medicine

CHAPTER 6. GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT AND INSTRUMENTS & SOFTWARE AND SERVICES

6.1. Introduction
  6.1.1. Reagents
  6.1.2. Instruments
  6.1.3. Software And Services

CHAPTER 7. GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY

7.1. Introduction
  7.1.1. Immunodiagnostics
  7.1.2. Hematology
  7.1.3. Molecular Diagnostics
  7.1.4. Tissue Diagnostics
  7.1.5. Clinical Chemistry
  7.1.6. Microbiology
  7.1.7. Coagulation & Hemostasis
  7.1.8. Others

CHAPTER 8. GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION

8.1. Introduction
  8.1.1. Infectious Diseases
  8.1.2. Oncology
  8.1.3. Endocrinology
  8.1.4. Cardiology
  8.1.5. Blood Screening
  8.1.6. Genetic Testing
  8.1.7. Autoimmune Diseases
  8.1.8. Allergy Diagnostics
  8.1.9. Bone & Mineral Disorders
  8.1.10. Coagulation Testing
  8.1.11. Others

CHAPTER 9. GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY END USER

9.1. Introduction
  9.1.1. Hospital & Clinics
  9.1.2. Clinical Laboratories
  9.1.3. Point of Care
  9.1.4. Pharmaceutical & Biotechnology Companies
  9.1.5. Academic Institutes
  9.1.6. Others

CHAPTER 10. GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY REGION

10.1. Introduction
10.2. North America
  10.2.1. North America: Market Size and Forecast, By Country, 2021 – 2034 ($ Million)
  10.2.2. North America: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million)
  10.2.3. North America: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million)
  10.2.4. North America: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
  10.2.5. North America: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
  10.2.6. US
    10.2.6.1. U.S.: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million)
    10.2.6.2. U.S.: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million)
    10.2.6.3. U.S.: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
    10.2.6.4. U.S.: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
  10.2.7. Canada
    10.2.7.1. Canada: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million)
    10.2.7.2. Canada: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million)
    10.2.7.3. Canada: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
    10.2.7.4. Canada: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
  10.2.8. Mexico
    10.2.8.1. Mexico: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million)
    10.2.8.2. Mexico: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million)
    10.2.8.3. Mexico: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
    10.2.8.4. Mexico: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
10.3. Europe
  10.3.1. Europe: Market Size and Forecast, By Country, 2021 – 2034 ($ Million)
  10.3.2. Europe: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million)
  10.3.3. Europe: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million)
  10.3.4. Europe: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
  10.3.5. Europe: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
  10.3.6. U.K.
    10.3.6.1. U.K.: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million)
    10.3.6.2. U.K.: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million)
    10.3.6.3. U.K.: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
    10.3.6.4. U.K.: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
  10.3.7. Germany
    10.3.7.1. Germany: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million)
    10.3.7.2. Germany: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million)
    10.3.7.3. Germany: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
    10.3.7.4. Germany: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
  10.3.8. France
    10.3.8.1. France: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million)
    10.3.8.2. France: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million)
    10.3.8.3. France: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
    10.3.8.4. France: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
  10.3.9. Italy
    10.3.9.1. Italy: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million)
    10.3.9.2. Italy: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million)
    10.3.9.3. Italy: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
    10.3.9.4. Italy: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
  10.3.10. Spain
    10.3.10.1. Spain: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million)
    10.3.10.2. Spain: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million)
    10.3.10.3. Spain: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
    10.3.10.4. Spain: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
  10.3.11. BeNeLux
    10.3.11.1. BeNeLux: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million)
    10.3.11.2. BeNeLux: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million)
    10.3.11.3. BeNeLux: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
    10.3.11.4. BeNeLux: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
  10.3.12. Russia
    10.3.12.1. Russia: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million)
    10.3.12.2. Russia: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million)
    10.3.12.3. Russia: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
    10.3.12.4. Russia: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
  10.3.13. Rest of Europe
    10.3.13.1. Rest of Europe: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million)
    10.3.13.2. Rest of Europe: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million)
    10.3.13.3. Rest of Europe: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
    10.3.13.4. Rest of Europe: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
10.4. Asia Pacific
  10.4.1. Asia Pacific: Market Size and Forecast, By Country, 2021 – 2034 ($ Million)
  10.4.2. Asia Pacific: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million)
  10.4.3. Asia Pacific: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million)
  10.4.4. Asia Pacific: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
  10.4.5. Asia Pacific: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
  10.4.6. China
    10.4.6.1. China: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million)
    10.4.6.2. China: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million)
    10.4.6.3. China: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
    10.4.6.4. China: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
  10.4.7. Japan
    10.4.7.1. Japan: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million)
    10.4.7.2. Japan: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million)
    10.4.7.3. Japan: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
    10.4.7.4. Japan: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
  10.4.8. Australia
    10.4.8.1. Australia: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million)
    10.4.8.2. Australia: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million)
    10.4.8.3. Australia: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
    10.4.8.4. Australia: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
  10.4.9. India
    10.4.9.1. India: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million)
    10.4.9.2. India: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million)
    10.4.9.3. India: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
    10.4.9.4. India: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
  10.4.10. South Korea
    10.4.10.1. South Korea: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million)
    10.4.10.2. South Korea: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million)
    10.4.10.3. South Korea: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
    10.4.10.4. South Korea: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
  10.4.11. Malaysia
    10.4.11.1. Malaysia: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million)
    10.4.11.2. Malaysia: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million)
    10.4.11.3. Malaysia: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
    10.4.11.4. Malaysia: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
  10.4.12. Thailand
    10.4.12.1. Thailand: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million)
    10.4.12.2. Thailand: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million)
    10.4.12.3. Thailand: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
    10.4.12.4. Thailand: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
  10.4.13. Indonesia
    10.4.13.1. Indonesia: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million)
    10.4.13.2. Indonesia: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million)
    10.4.13.3. Indonesia: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
    10.4.13.4. Indonesia: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
  10.4.14. Rest of Asia Pacific
    10.4.14.1. Rest of Asia Pacific: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million)
    10.4.14.2. Rest of Asia Pacific: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million)
    10.4.14.3. Rest of Asia Pacific: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
    10.4.14.4. Rest of Asia Pacific: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
10.5. South America
  10.5.1. South America: Market Size and Forecast, By Country, 2021 – 2034 ($ Million)
  10.5.2. South America: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million)
  10.5.3. South America: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million)
  10.5.4. South America: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
  10.5.5. South America: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
  10.5.6. Brazil
    10.5.6.1. Brazil: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million)
    10.5.6.2. Brazil: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million)
    10.5.6.3. Brazil: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
    10.5.6.4. Brazil: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
  10.5.7. Argentina
    10.5.7.1. Argentina: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million)
    10.5.7.2. Argentina: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million)
    10.5.7.3. Argentina: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
    10.5.7.4. Argentina: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
  10.5.8. Rest of South America
    10.5.8.1. Rest of South America: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million)
    10.5.8.2. Rest of South America: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million)
    10.5.8.3. Rest of South America: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
    10.5.8.4. Rest of South America: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
10.6. Middle East & Africa
  10.6.1. Middle East & Africa: Market Size and Forecast, By Country, 2021 – 2034 ($ Million)
  10.6.2. Middle East & Africa: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million)
  10.6.3. Middle East & Africa: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million)
  10.6.4. Middle East & Africa: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
  10.6.5. Middle East & Africa: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
  10.6.6. Saudi Arabia
    10.6.6.1. Saudi Arabia: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million)
    10.6.6.2. Saudi Arabia: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million)
    10.6.6.3. Saudi Arabia: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
    10.6.6.4. Saudi Arabia: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
  10.6.7. UAE
    10.6.7.1. UAE: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million)
    10.6.7.2. UAE: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million)
    10.6.7.3. UAE: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
    10.6.7.4. UAE: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
  10.6.8. Egypt
    10.6.8.1. Egypt: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million)
    10.6.8.2. Egypt: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million)
    10.6.8.3. Egypt: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
    10.6.8.4. Egypt: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
  10.6.9. South Africa
    10.6.9.1. South Africa: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million)
    10.6.9.2. South Africa: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million)
    10.6.9.3. South Africa: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
    10.6.9.4. South Africa: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
  10.6.10. Rest of Middle East & Africa
    10.6.10.1. Rest of Middle East & Africa: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million)
    10.6.10.2. Rest of Middle East & Africa: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million)
    10.6.10.3. Rest of Middle East & Africa: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
    10.6.10.4. Rest of Middle East & Africa: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)

CHAPTER 11. COMPETITIVE LANDSCAPE

11.1. Competitior Benchmarking 2023
11.2. Market Share Analysis, 2022
11.3. Key Developments Analysis By Top 5 Companies
11.4. Market Share Acquisition Strategies: Analysis of Key Approaches Employed by Top Players

CHAPTER 12. COMPANY PROFILES

12.1. Abbott Laboratories
  12.1.1. Business Overview
  12.1.2. Financial Analysis12.1.2.1. Business Segment Revenue, 2023
    12.1.2.2. Geographic Revenue Mix, 2023
  12.1.3. Product Portfolio
  12.1.4. Recent Development and Strategies Adopted
  12.1.5. SWOT Analysis
12.2. Becton, Dickinson, and Company
  12.2.1. Business Overview
  12.2.2. Financial Analysis
    12.2.2.1. Business Segment Revenue, 2023
    12.2.2.2. Geographic Revenue Mix, 2023
  12.2.3. Product Portfolio
  12.2.4. Recent Development and Strategies Adopted
  12.2.5. SWOT Analysis
12.3. BIOMERIEUX
  12.3.1. Business Overview
  12.3.2. Financial Analysis
    12.3.2.1. Business Segment Revenue, 2023
    12.3.2.2. Geographic Revenue Mix, 2023
  12.3.3. Product Portfolio
  12.3.4. Recent Development and Strategies Adopted
12.4. Bio-Rad Laboratories Inc
  12.4.1. Business Overview
  12.4.2. Financial Analysis
    12.4.2.1. Business Segment Revenue, 2023
    12.4.2.2. Geographic Revenue Mix, 2023
  12.4.3. Product Portfolio
  12.4.4. Recent Development and Strategies Adopted
12.5. Danaher Corporation
  12.5.1. Business Overview
  12.5.2. Financial Analysis
    12.5.2.1. Business Segment Revenue, 2023
    12.5.2.2. Geographic Revenue Mix, 2023
  12.5.3. Product Portfolio
  12.5.4. Recent Development and Strategies Adopted
  12.5.5. SWOT Analysis
12.6. Hoffmann-La Roche
  12.6.1. Business Overview
  12.6.2. Financial Analysis
    12.6.2.1. Business Segment Revenue, 2023
    12.6.2.2. Geographic Revenue Mix, 2023
  12.6.3. Product Portfolio
  12.6.4. Recent Development and Strategies Adopted
  12.6.5. SWOT Analysis
12.7. Siemens Healthineers AG
  12.7.1. Business Overview
  12.7.2. Financial Analysis
    12.7.2.1. Business Segment Revenue, 2023
    12.7.2.2. Geographic Revenue Mix, 2023
  12.7.3. Product Portfolio
  12.7.4. Recent Development and Strategies Adopted
12.8. QIAGEN N.V.
  12.8.1. Business Overview
  12.8.2. Financial Analysis
    12.8.2.1. Business Segment Revenue, 2023
    12.8.2.2. Geographic Revenue Mix, 2023
  12.8.3. Product Portfolio
  12.8.4. Recent Development and Strategies Adopted
12.9. Sysmex Corporation
  12.9.1. Business Overview
  12.9.2. Financial Analysis
    12.9.2.1. Geographic Revenue Mix, 2023
  12.9.3. Product Portfolio
  12.9.4. Recent Development and Strategies Adopted
12.10. THERMO FISHER SCIENTIFIC INC
  12.10.1. Business Overview
  12.10.2. Financial Analysis
    12.10.2.1. Business Segment Revenue, 2023
    12.10.2.2. Geographic Revenue Mix, 2023
  12.10.3. Product Portfolio
  12.10.4. Recent Development and Strategies Adopted
  12.10.5. SWOT Analysis